Jane Street’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,957
Closed -$417K 10578
2022
Q3
$417K Sell
19,957
-902
-4% -$25.8K ﹤0.01% 7015
2022
Q2
$668K Buy
20,859
+11,268
+117% +$425K ﹤0.01% 6210
2022
Q1
$391K Buy
+9,591
New +$402K ﹤0.01% 7920
2021
Q2
Sell
-13,693
Closed -$628K 10684
2021
Q1
$628K Buy
+13,693
New +$657K ﹤0.01% 6381
2020
Q3
Sell
-45,441
Closed -$1.75M 8205
2020
Q2
$1.75M Buy
+45,441
New +$1.84M ﹤0.01% 3252

Other funds holding ELAT

Jane Street's ELAT Position: Q4 2022 in Review

Jane Street sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 19,957 shares — an estimated $417K sold.

Jane Street first reported a position in ELAT in Q2 2020 and held it in 5 quarters. The position peaked at $1.75M in Q2 2020. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • Jane Street reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 19,957 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $417K.
  • Jane Street first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q2 2020 and held it in 5 quarters.
  • Jane Street's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $1.75M in Q2 2020.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.